about
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareThe stressed synapse: the impact of stress and glucocorticoids on glutamate transmissionDual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsCan variation in hypothalamic-pituitary-adrenal (HPA)-axis activity explain the relationship between depression and cognition in bipolar patients?Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?Hippocampal changes associated with early-life adversity and vulnerability to depression.A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.COMORBIDITY BETWEEN DEPRESSIVE AND ADDICTIVE DISORDERS IN ADOLESCENTS: ROLE OF STRESS AND HPA ACTIVITY.Longitudinal course of adolescent depression: neuroendocrine and psychosocial predictors.Molecular signatures of mood stabilisers highlight the role of the transcription factor REST/NRSF.Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study).Of sound mind and body: depression, disease, and accelerated agingTwo diagnoses become one? Rare case report of anorexia nervosa and Cushing's syndrome.Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania.Metyrapone in treatment-resistant depression.Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: interactions between stress and HPA activity.Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents.The chronic mild stress (CMS) model of depression: History, evaluation and usageMood Therapeutics: Novel Pharmacological Approaches for Treating DepressionThe Limbic System in Youth Depression: Brain Structural and Functional Alterations in Adolescent In-patients with Severe Depression.
P2860
Q26851160-D5D4C87C-3896-4778-B413-557CA7DADEC6Q26859198-9FD0197D-3513-441B-96F0-0966F9956752Q28305100-6DBC6CCD-234E-4732-A796-164220CBEB85Q28729989-70717E5E-2805-40D5-ADA1-50E882F0BB6EQ30454937-79D6806F-9685-4ECA-84C7-767F63A25F3FQ33649329-1F8A26F4-99B3-4F70-BCD6-5CDDE24DD939Q33751814-E0107B60-F273-46CF-8640-7DAB14CFC2B2Q33989571-5E43AB4E-45E6-48C9-8923-571045C2529EQ34010156-F02A8D85-83DC-4083-B84A-CE4288333CECQ34742694-B1BB4D47-AECD-4C51-B292-97737942E1F1Q34893388-6668A915-68F1-424E-A10C-7231B1868C98Q35237227-F568384B-10D4-4BA7-8420-A4581D839D58Q36753406-66B1FAEB-BC18-4F8D-9B5E-176490D3933BQ36899381-EBADDBFD-8D32-415C-A38A-69F6C9576E97Q36929705-50364B8F-39C7-47D4-AC24-C324BC7F2545Q37079032-612AE8D9-BACE-48FE-9C92-61AA62A8CDE8Q37183514-68870B72-BC31-497E-AD38-F3622859A024Q37405912-5F7D56BE-9C8E-4719-A612-852D7455DD21Q37442176-07FDE537-37E8-479F-B5BD-48ED25C20346Q37648894-13FD67E3-BE91-428A-B5F8-A5AF73F75EA0Q38990885-BE0404D8-E7B9-4AA9-BDFD-34169E4AEDFEQ47736820-8F7B665A-CA6E-4936-A8C1-99E36643A76B
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antiglucocorticoid treatments for mood disorders
@ast
Antiglucocorticoid treatments for mood disorders
@en
Antiglucocorticoid treatments for mood disorders
@en-gb
Antiglucocorticoid treatments for mood disorders
@nl
type
label
Antiglucocorticoid treatments for mood disorders
@ast
Antiglucocorticoid treatments for mood disorders
@en
Antiglucocorticoid treatments for mood disorders
@en-gb
Antiglucocorticoid treatments for mood disorders
@nl
prefLabel
Antiglucocorticoid treatments for mood disorders
@ast
Antiglucocorticoid treatments for mood disorders
@en
Antiglucocorticoid treatments for mood disorders
@en-gb
Antiglucocorticoid treatments for mood disorders
@nl
P2093
P2860
P1476
Antiglucocorticoid treatments for mood disorders
@en
P2093
P2860
P304
P356
10.1002/14651858.CD005168.PUB2
P577
2008-01-23T00:00:00Z